ArticleCrohn's & colitis 3602023

Tixagevimab and Cilgavimab (Evusheld) as Pre-exposure Prophylaxis for COVID-19 in Patients With Inflammatory Bowel Disease: A Propensity Matched Cohort Study.

Aakash Desai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.